COVID-19TRIPS 2021: A Changed IP Landscape for Defeating COVID-19January 28, 2021 New Year’s Day 2021 was a nail-biter. Hope from the rollout of 95% effective COVID-19…Doris Estelle Long COVID-19Vaccines The Under-Appreciated Virtue of Transparency in Combatting COVID-19December 3, 2020 With the Center for Disease Control finally moving forward with its task of providing critical…Doris Estelle Long COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through InformationOctober 21, 2020 This is Part II of a two-part article examining the changes that we need in…Doris Estelle Long COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure SystemOctober 5, 2020 This is Part 1 of a two-part article examining the changes that we need in…Doris Estelle Long COVID-19 Stopping the Spread of Counterfeit Medicine in the Age of COVID-19July 30, 2020 The COVID-19 pandemic poses a global threat to the health and safety of individuals everywhere,…Lisa A. DunnerJulia Schroeder COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19ExhaustionPatents TRIPS, COVID-19, and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 1 of 2)June 11, 2020 This is Part 1 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Patents Compulsory Licensing or Patent Pools – What is the Intellectual Property Answer to COVID-19?June 3, 2020 The COVID-19 health emergency has seen different reactions from states in an attempt to curb…Mustafa RajkotwalaVidisha Singh COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) COVID-19 (24) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (4) TRIPS (22) TRIPS Flexibilities (4) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (3) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine Waive Intellectual Property Rights & Save Lives Human Rights and Intellectual Property Rights Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and Pharmaceuticals
COVID-19Vaccines The Under-Appreciated Virtue of Transparency in Combatting COVID-19December 3, 2020 With the Center for Disease Control finally moving forward with its task of providing critical…Doris Estelle Long COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through InformationOctober 21, 2020 This is Part II of a two-part article examining the changes that we need in…Doris Estelle Long COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure SystemOctober 5, 2020 This is Part 1 of a two-part article examining the changes that we need in…Doris Estelle Long COVID-19 Stopping the Spread of Counterfeit Medicine in the Age of COVID-19July 30, 2020 The COVID-19 pandemic poses a global threat to the health and safety of individuals everywhere,…Lisa A. DunnerJulia Schroeder COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19ExhaustionPatents TRIPS, COVID-19, and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 1 of 2)June 11, 2020 This is Part 1 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Patents Compulsory Licensing or Patent Pools – What is the Intellectual Property Answer to COVID-19?June 3, 2020 The COVID-19 health emergency has seen different reactions from states in an attempt to curb…Mustafa RajkotwalaVidisha Singh COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) COVID-19 (24) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (4) TRIPS (22) TRIPS Flexibilities (4) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (3) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine Waive Intellectual Property Rights & Save Lives Human Rights and Intellectual Property Rights Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and Pharmaceuticals
COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through InformationOctober 21, 2020 This is Part II of a two-part article examining the changes that we need in…Doris Estelle Long COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure SystemOctober 5, 2020 This is Part 1 of a two-part article examining the changes that we need in…Doris Estelle Long COVID-19 Stopping the Spread of Counterfeit Medicine in the Age of COVID-19July 30, 2020 The COVID-19 pandemic poses a global threat to the health and safety of individuals everywhere,…Lisa A. DunnerJulia Schroeder COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19ExhaustionPatents TRIPS, COVID-19, and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 1 of 2)June 11, 2020 This is Part 1 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Patents Compulsory Licensing or Patent Pools – What is the Intellectual Property Answer to COVID-19?June 3, 2020 The COVID-19 health emergency has seen different reactions from states in an attempt to curb…Mustafa RajkotwalaVidisha Singh COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) COVID-19 (24) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (4) TRIPS (22) TRIPS Flexibilities (4) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (3) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine Waive Intellectual Property Rights & Save Lives Human Rights and Intellectual Property Rights Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and Pharmaceuticals
COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure SystemOctober 5, 2020 This is Part 1 of a two-part article examining the changes that we need in…Doris Estelle Long COVID-19 Stopping the Spread of Counterfeit Medicine in the Age of COVID-19July 30, 2020 The COVID-19 pandemic poses a global threat to the health and safety of individuals everywhere,…Lisa A. DunnerJulia Schroeder COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19ExhaustionPatents TRIPS, COVID-19, and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 1 of 2)June 11, 2020 This is Part 1 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Patents Compulsory Licensing or Patent Pools – What is the Intellectual Property Answer to COVID-19?June 3, 2020 The COVID-19 health emergency has seen different reactions from states in an attempt to curb…Mustafa RajkotwalaVidisha Singh COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) COVID-19 (24) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (4) TRIPS (22) TRIPS Flexibilities (4) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (3) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine Waive Intellectual Property Rights & Save Lives Human Rights and Intellectual Property Rights Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and Pharmaceuticals
COVID-19 Stopping the Spread of Counterfeit Medicine in the Age of COVID-19July 30, 2020 The COVID-19 pandemic poses a global threat to the health and safety of individuals everywhere,…Lisa A. DunnerJulia Schroeder COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19ExhaustionPatents TRIPS, COVID-19, and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 1 of 2)June 11, 2020 This is Part 1 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Patents Compulsory Licensing or Patent Pools – What is the Intellectual Property Answer to COVID-19?June 3, 2020 The COVID-19 health emergency has seen different reactions from states in an attempt to curb…Mustafa RajkotwalaVidisha Singh COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) COVID-19 (24) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (4) TRIPS (22) TRIPS Flexibilities (4) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (3) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine Waive Intellectual Property Rights & Save Lives Human Rights and Intellectual Property Rights Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and Pharmaceuticals
COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19ExhaustionPatents TRIPS, COVID-19, and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 1 of 2)June 11, 2020 This is Part 1 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Patents Compulsory Licensing or Patent Pools – What is the Intellectual Property Answer to COVID-19?June 3, 2020 The COVID-19 health emergency has seen different reactions from states in an attempt to curb…Mustafa RajkotwalaVidisha Singh COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) COVID-19 (24) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (4) TRIPS (22) TRIPS Flexibilities (4) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (3) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine Waive Intellectual Property Rights & Save Lives Human Rights and Intellectual Property Rights Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and Pharmaceuticals
COVID-19ExhaustionPatents TRIPS, COVID-19, and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 1 of 2)June 11, 2020 This is Part 1 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Patents Compulsory Licensing or Patent Pools – What is the Intellectual Property Answer to COVID-19?June 3, 2020 The COVID-19 health emergency has seen different reactions from states in an attempt to curb…Mustafa RajkotwalaVidisha Singh COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) COVID-19 (24) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (4) TRIPS (22) TRIPS Flexibilities (4) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (3) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine Waive Intellectual Property Rights & Save Lives Human Rights and Intellectual Property Rights Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and Pharmaceuticals
COVID-19Patents Compulsory Licensing or Patent Pools – What is the Intellectual Property Answer to COVID-19?June 3, 2020 The COVID-19 health emergency has seen different reactions from states in an attempt to curb…Mustafa RajkotwalaVidisha Singh COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) COVID-19 (24) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (4) TRIPS (22) TRIPS Flexibilities (4) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (3) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine Waive Intellectual Property Rights & Save Lives Human Rights and Intellectual Property Rights Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and Pharmaceuticals
COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) COVID-19 (24) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (4) TRIPS (22) TRIPS Flexibilities (4) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (3) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine Waive Intellectual Property Rights & Save Lives Human Rights and Intellectual Property Rights Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and Pharmaceuticals
COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next